|
Forecast Period
|
2026-2030
|
|
Market Size (2024)
|
USD 128.45 Million
|
|
Market Size (2030)
|
USD 116.62 Million
|
|
CAGR (2025-2030)
|
0.41%
|
|
Fastest Growing Segment
|
Continuous Flow
|
|
Largest Market
|
North India
|
Market Overview
India Oxygen Concentrators Market was valued at USD 128.45 Million in 2024 and is anticipated to reach USD 116.62 Million by 2030, with a CAGR of 0.41% during 2025-2030. The oxygen concentrators market in India is a rapidly growing segment within the healthcare industry, focused on the production, distribution, and sale of devices that extract and purify oxygen from ambient air to provide a continuous supply for patients. These devices play a vital role in oxygen therapy, supporting individuals with respiratory conditions. Increasing demand for reliable, portable, and cost-effective oxygen delivery systems, along with the rising prevalence of respiratory disorders, is driving market expansion and attracting both domestic and international participants.
The market’s growth is supported by ongoing technological advancements and collaborative efforts across the healthcare ecosystem. Manufacturers are investing in research and development to improve device efficiency, performance, and ease of use, making oxygen concentrators more accessible to a broader population. At the same time, partnerships between healthcare providers, medical device companies, and government bodies are helping expand availability and strengthen supply networks. This continued development is enhancing access to oxygen therapy and supporting better healthcare delivery across India.
Key Market Drivers
Increasing Prevalence of Respiratory Disorders
The increasing incidence of respiratory disorders in India is materially strengthening demand for oxygen concentrators, as chronic conditions such as COPD and asthma are being aggravated by worsening air pollution, tobacco exposure, and other environmental risks that create a sustained need for oxygen support across hospitals, clinics, and home care settings. The burden is especially intense in urban and industrialized regions, where pollution-linked respiratory stress is higher and where patients increasingly require reliable devices that can deliver oxygen-enriched air without depending fully on cylinder-based supply systems.
This makes oxygen concentrators essential not only for acute episodes but also for long-term disease management, because they help stabilize oxygen saturation, reduce hospitalization pressure, and improve day-to-day functioning for people living with severe respiratory impairment. Demand is also being reinforced by healthcare system preparedness, as providers and policymakers now treat concentrator availability as a core part of respiratory infrastructure rather than a temporary emergency response measure. For Instance, a multicentre Indian survey across 302 sites covering 25,177 adults found asthma accounted for 29.8 percent of respiratory diagnoses and COPD for 15.6 percent, while PIB reported that 1,14,000 oxygen concentrators were being supplied to states under PM CARES and ECRP II and Apollo Homecare offers oxygen concentrators with capacities up to 10 litres per minute.
Rising Geriatric Population
The rising geriatric population in India is becoming a major demand driver for oxygen concentrators because ageing is closely linked with a higher incidence of chronic respiratory conditions such as COPD, asthma, and other lung disorders that often require long-term oxygen support at home or in supervised care settings. This trend is gaining strength as older adults increasingly seek devices that are reliable, easy to use, and suitable for continuous respiratory assistance without repeated dependence on hospital-based oxygen delivery.
Oxygen concentrators fit this need well because they offer a practical homecare solution that improves mobility, comfort, and treatment continuity, especially for elderly patients managing chronic illness over extended periods. The market is also benefiting from broader healthcare access and stronger awareness of home-based care, which is encouraging families to adopt concentrators as part of routine elderly respiratory management rather than only as an emergency purchase. For Instance, SBI Research estimated that India’s elderly population crossed 150 million in 2024, while chronic respiratory disease data show COPD cases in India rose to 55.3 million in 2016, and Apollo HomeCare offers oxygen concentrators for home use priced at 68,000 rupees, clearly reflecting how ageing and chronic lung disease are translating into sustained device demand.
Growing Preference for Home-Based Therapy
The demand for oxygen concentrators in India has risen significantly in recent years, and one of the clearest drivers is the growing preference for home-based therapy among patients who need dependable respiratory support without repeated hospital visits. This shift is especially important for people living with chronic respiratory diseases, because treatment at home offers greater comfort, lower care disruption, and better continuity for long-term oxygen use than facility-dependent care alone. As India’s population ages and healthcare delivery becomes more decentralized, oxygen concentrators are becoming a practical part of home healthcare, helping patients preserve daily routines while still receiving medically necessary oxygen therapy.
The trend is also supported by rising awareness of respiratory disease management and stronger acceptance of tele-follow-up and remote care models, which make home treatment more feasible for both urban and semi-urban populations. Providers are responding by expanding rental, sale, setup, and maintenance models that make concentrators easier to access and sustain over time in non-hospital settings. For Instance, Apollo HomeCare offers oxygen concentrators on rent or sale across cities such as Hyderabad, Bangalore, Kolkata, Chennai, and Delhi, and its OxyFlow 5 provides up to 5 litres per minute of continuous oxygen therapy, while a Haryana study successfully contacted 284 of 289 registered chronic respiratory patients and completed tele-follow-up for 218, underlining the growing viability of home-based respiratory care in India.
Rising Demand for Portable Oxygen Concentrators
India’s healthcare industry is seeing strong momentum in oxygen concentrator demand, with portable oxygen concentrators emerging as a particularly important growth avenue because they match the country’s rising need for flexible home-based respiratory support. Portable models are increasingly preferred by patients who want mobility, ease of handling, and the ability to maintain daily activities while continuing oxygen therapy, which makes them especially relevant for seniors, post-acute patients, and people with chronic respiratory illness.
Their compact form and battery-powered functionality have become more valuable since the pandemic period, when the importance of dependable oxygen access outside hospital settings became widely recognized across India. This demand is being reinforced by the expanding home healthcare ecosystem and by product innovation from both domestic and international brands that are tailoring solutions for portability, usability, and broader geographic access. For Instance, Oxymed’s P2 portable oxygen concentrator launched for the Indian market weighs just 1.98 kilograms, delivers 90 to 95 percent oxygen purity, offers up to 10 hours of use with a double battery, and is supported by home installation and service in 50 Indian cities, clearly showing why portable devices are becoming central to oxygen therapy adoption in India.
Download Free Sample Report
Key Market Challenges
High Product Cost
High product cost remains a major barrier to wider oxygen concentrator adoption in India, because these devices still represent a significant one-time expense for households that often manage respiratory care through personal savings rather than dedicated medical-device budgets. This affordability challenge is particularly severe for middle- and lower-income families, as even standard stationary units can be difficult to purchase outright, while advanced portable models add a further premium for mobility, battery support, and compact engineering. The cost burden also extends beyond the device itself, since maintenance, accessories, and long-duration home use can raise the total financial commitment and make concentrators less accessible outside affluent urban consumers.
Limited reimbursement compounds the problem, because partial insurance support does not always fully offset the purchase price, leaving many patients to delay adoption, rent equipment temporarily, or depend on less convenient alternatives. For Instance, Apollo HomeCare lists a 5 litre oxygen concentrator at 45,939 rupees and another home oxygen concentrator at 68,000 rupees, while government reimbursement ceilings cited under CGHS and CS MA guidelines are 45,000 rupees for oxygen concentrators, highlighting the persistent out-of-pocket gap for patients.
Sanitization and quality concerns
Sanitization and quality-related concerns remain a restraint in the India oxygen concentrators market because buyers are often willing to use these devices only when they are confident that hygiene practices, maintenance routines, and safety standards are clearly defined and consistently followed. The issue becomes more significant in homecare settings, where users may not have clinical training and where uncertainty around filter cleaning, humidifier disinfection, and servicing intervals can weaken trust in long-term device use. While guidance does exist, adoption can still be affected when standardized cleaning discipline is not translated into everyday practice by sellers, caregivers, and patients, particularly for reused or rented devices.
This makes quality assurance and after-sales education critical for the market, because strong device performance alone is not enough if end users remain uncertain about safe usage and contamination control. For Instance, WHO recommends that concentrator humidifiers be washed, rinsed, and disinfected daily, air intake filters be cleaned one to two times per week, and stored devices be cleaned twice a month, while CDSCO instructed sellers to prominently display technical maintenance protocols for each model, showing that trust in concentrators depends heavily on visible and standardized upkeep practices.
Strict Regulatory Barriers
Manufacturers in India’s oxygen concentrator market operate within a demanding regulatory environment where licensing, quality management, technical documentation, and in some cases clinical investigation requirements can materially raise compliance costs and delay commercialization. The challenge has intensified as India’s medical device regime has become more structured, with oxygen concentrators and other respiratory devices facing closer scrutiny on safety, testing, and approval readiness, which means even minor documentation gaps or unresolved queries can slow market entry.
For many companies, the burden is not only regulatory complexity itself but the need to align manufacturing systems with validated standards, maintain audit readiness, and navigate multiple approval stages without disrupting supply plans in a price-sensitive healthcare market. This makes regulatory capability a competitive differentiator, because manufacturers that can manage licensing efficiently are better positioned to launch products faster and respond to spikes in oxygen demand across hospitals and homecare channels. For Instance, Nexdigm reported that in 2022 only 144 of 247 domestic and international medical device manufacturers registered their products efficiently, while CDSCO rules place import of all medical devices and manufacture of Class C and D devices under the central licensing authority, underscoring how compliance intensity can slow oxygen concentrator rollouts.
Key Market Trends
Escalating Demand by Travelers and Mountaineers
The growing interest in adventure tourism and high-altitude travel is creating a niche but visible demand stream for oxygen concentrators in India, particularly for portable models that can support travelers in low-oxygen environments where breathlessness, fatigue, and altitude-related discomfort become more common. As trekking, mountaineering, and Himalayan travel gain wider appeal, travelers are placing greater emphasis on preparedness and mobility, which makes compact oxygen support devices more relevant than stationary units designed mainly for home or hospital use.
Portable oxygen concentrators fit this requirement well because they combine oxygen delivery with battery-powered convenience, allowing users to maintain movement during travel while reducing dependence on bulky oxygen alternatives. This does not make adventure travel the largest demand driver in the market, but it does expand the application base by linking oxygen support with safety-conscious leisure mobility in destinations where altitude can materially affect comfort and health. For Instance, Ministry of Tourism data show domestic tourist arrivals in 2024 reached 2,92,836 in Leh and 3,20,432 in Kargil, while Oxymed’s P2 portable concentrator weighs 1.98 kilograms and offers up to 10 hours of backup with a double battery, highlighting why lightweight oxygen devices are increasingly relevant for high-altitude travel.
Technological Advancements
Technological advancement is playing a major role in driving demand for oxygen concentrators in India, as recent health emergencies pushed hospitals, homecare providers, and policymakers to prioritize devices that are more reliable, efficient, and easier to use across varied care settings. Innovation is no longer limited to oxygen delivery alone, because newer systems are being designed with better purity control, improved portability, simpler interfaces, and smarter operational features that help patients and caregivers manage therapy more confidently. These improvements have widened the practical use of concentrators beyond major hospitals by making them more suitable for homecare, smaller facilities, and semi-urban or remote healthcare environments where consistent oxygen access can otherwise be difficult.
At the same time, indigenous design and local manufacturing are helping strengthen supply resilience, speed up deployment, and reduce dependence on emergency imports during periods of high demand. For Instance, the Department of Science and Technology said Walnut Medical developed 5 litre and 10 litre portable medical grade oxygen concentrators in India using PSA technology with oxygen purity above 96 percent at 55 to 75 kPa, demonstrating how domestic innovation is improving product performance and market readiness.
Segmental Insights
Type Insights
Based on the type, in the
Indian Oxygen Concentrators market, the Portable type is projected to dominate
due to several factors. Rising demand for lightweight, portable oxygen concentrators is driven by an aging population and increasing cases of chronic respiratory conditions. These devices offer convenience and flexibility, enabling patients to continue oxygen therapy while traveling or performing daily activities. Their portability enhances quality of life by promoting independence and reducing reliance on bulky stationary systems. With compact designs and advanced features, portable concentrators are transforming respiratory care. Growing awareness and continuous innovation by manufacturers are further strengthening their appeal. In India, their adoption is accelerating due to ease of use, reliability, and mobility benefits. As technology advances and patient needs evolve, portable oxygen concentrators are expected to remain the preferred solution for efficient and convenient respiratory support.
Technology Insights
Based on technology,
Continuous Flow category will continue to dominate the Oxygen Concentrators
Market in India. The dominance of continuous flow oxygen concentrators is largely driven by their reliability and ability to deliver a consistent, high oxygen output. These features make them ideal for patients with severe respiratory conditions or those requiring intensive care support. By providing a steady oxygen supply, they help improve breathing efficiency, reduce symptoms, and enhance overall health outcomes. This leads to fewer hospital visits and enables patients to maintain a more stable and independent lifestyle. Increasing awareness of respiratory health and the growing burden of chronic diseases further support their adoption. As healthcare systems in India focus on effective and dependable treatment solutions, continuous flow oxygen concentrators are expected to remain essential in delivering high-quality patient care.
Download Free Sample Report
Regional Insights
The North region of India, particularly the Delhi
NCR area, is currently experiencing significant dominance in the Oxygen
Concentrators Market. This can be attributed to various factors, including the
exceptionally high population density in this region and the subsequent surge
in medical requirements resulting from recent health crises. The
region's advanced healthcare infrastructure plays a crucial role in the growth
of the Oxygen Concentrators Market. With state-of-the-art hospitals and medical
facilities, the North region ensures efficient and timely access to critical
care equipment like oxygen concentrators. This availability of top-tier
healthcare resources contributes to the region's reputation as a hub for
medical advancements and technological innovations.
The presence of renowned medical research
institutions in the North region further strengthens its position as a leader
in the industry. These institutions, coupled with the expertise of highly
skilled healthcare professionals, drive continuous progress in the field of
medical technology. All these factors combined create a highly favorable and
conducive environment for the growth and expansion of the Oxygen Concentrators
Market in the North region of India, solidifying its leading position in the
industry. With a focus on meeting the increasing demand for medical equipment,
the region continues to thrive and contribute to the overall healthcare
landscape in the country.
Regional Insights
- In March 2025, the Ministry of Health and Family Welfare released the National Guidelines on Medical Oxygen Management at a workshop held at AIIMS Delhi. This was relevant to the oxygen concentrator segment because the guidelines were presented as a step toward strengthening India’s medical oxygen infrastructure and standardizing best practices for oxygen management across healthcare facilities.
- In March 2025, AIIMS Delhi workshop marked the launch of the National Capacity Building Programme on Oxygen Management. The programme was described as being led by the Department of Hospital Administration at AIIMS Delhi, making it an important operational development for concentrator use because it aimed to improve institutional handling, training, and oxygen-system readiness nationwide.
- In January 2026, BioSpectrum India reported that Oxymed unveiled Cure, a new 5 LPM oxygen concentrator for the Indian market. The launch was positioned around affordability and dependable home oxygen therapy, with reports saying the device was designed to make oxygen support more accessible without compromising medical or service standards.
- In February 2026, Oxymed introduced Inteli 5 LPM alongside Cure, expanding its home oxygen concentrator portfolio in India. The Inteli model stood out as a breakthrough innovation because BioSpectrum said it was India’s first home oxygen concentrator capable of automatically adjusting oxygen flow based on real-time patient SpO₂, signaling a shift toward smarter and more personalized oxygen therapy.
Key Market Players
- Philips India Limited
- BPL Medical Technologies Private Limited
- Nidek Medical India Private Limited
- Sanrai Med India Private Limited
- Kannu Impex (India) Private Limited
- Monarch Meditech
- MediKart HealthCare Systems Private Limited
- Technocare Medisystems
- GPC Medical Limited
- Nareena Life Sciences Private Limited
|
By Type
|
By Technology
|
By Flowrate
|
By Source
|
By Offering
|
By Application
|
By Distribution Channel
|
By End User
|
By Region
|
|
|
- Continuous Flow
- Pulse Flow
- Continuous/Pulse Flow
|
- 5l/min
- 5-10l/min
- Above 10l/min
|
|
|
- COPD
- Lung Cancer
- Asthma
- COVID-19
- Others
|
- Wholesalers/Distributors/Suppliers
- Online
- Direct Sales
|
- Hospitals & Clinics
- Ambulatory Care Centers
- Home Care
|
|
Report Scope:
In this report, the India Oxygen Concentrators
Market has been segmented into the following categories, in addition to the
industry trends which have also been detailed below:
- India Oxygen Concentrators
Market, By
Type:
o Portable
o Stationary
- India Oxygen Concentrators
Market, By
Technology:
o Continuous Flow
o Pulse Flow
o Continuous/Pulse Flow
- India Oxygen Concentrators
Market, By
Flowrate:
o 5l/min
o 5-10l/min
o Above 10l/min
- India Oxygen Concentrators
Market, By
Source:
o Import
o Domestic
- India Oxygen Concentrators
Market, By
Offering:
o Rental
o New Sales
- India Oxygen Concentrators
Market, By
Application:
o COPD
o Lung Cancer
o Asthma
o COVID-19
o Others
- India Oxygen Concentrators
Market, By
Distribution Channel:
o Wholesalers/Distributors/Suppliers
o Online
o Direct Sales
- India Oxygen Concentrators
Market, By
End User:
o Hospitals & Clinics
o Ambulatory Care Centers
o Home Care
- India Oxygen Concentrators
Market, By
Region:
o North
o South
o West
o East
Competitive Landscape
Company Profiles: Detailed analysis of the major companies
present in the India Oxygen Concentrators Market.
Available Customizations:
India Oxygen Concentrators Market report with
the given market data, Tech Sci Research offers customizations according to a
company's specific needs. The following customization options are available for
the report:
Company Information
- Detailed analysis and
profiling of additional market players (up to five).
India Oxygen Concentrators Market is an upcoming
report to be released soon. If you wish an early delivery of this report or
want to confirm the date of release, please contact us at [email protected]